2seventy bio Inc (TSVT)
4.785
-0.22
(-4.30%)
USD |
NASDAQ |
May 17, 16:00
4.785
0.00 (0.00%)
After-Hours: 20:00
2seventy bio Revenue (Annual): 100.39M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 100.39M |
| December 31, 2022 | 91.50M |
| December 31, 2021 | 54.52M |
| Date | Value |
|---|---|
| December 31, 2020 | 248.12M |
| December 31, 2019 | 44.30M |
| December 31, 2018 | 54.58M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
44.30M
Minimum
2019
248.12M
Maximum
2020
107.76M
Average
91.50M
Median
2022
Revenue (Annual) Benchmarks
| Bristol-Myers Squibb Co | 45.01B |
| Johnson & Johnson | 85.16B |
| Macrogenics Inc | 57.19M |
| Akebia Therapeutics Inc | 194.62M |
| Tango Therapeutics Inc | 36.53M |